Dr. Neil Cornwell, a family medicine physician in Boston completing his residency, has struggled with anxiety “for quite some time,” but was never able to put a label on it, he tells TODAY.com. So when he and his fiancée adopted a dog with…
Category: 6. Health
-
Ultra-Processed Foods Linked to Alarming Differences in Brain Structure – SciTechDaily
- Ultra-Processed Foods Linked to Alarming Differences in Brain Structure SciTechDaily
- Ultra-processed foods stimulate dopamine and are addictive? Latest science challenges activist consensus Genetic Literacy Project
- The Junk Foods That Harm Your…
Continue Reading
-
Just a moment…
Just a moment… This request seems a bit unusual, so we need to confirm that you’re human. Please press and hold the button until it turns completely green. Thank you for your cooperation!
Continue Reading
-
WHO voices concerns about equitable access to novel TB vaccines
angelp / iStock A new report from the World Health Organization (WHO) is calling for bold steps to ensure equitable access to future tuberculosis (TB) vaccines.
Although there is one currently licensed vaccine for TB, its age—it was first…
Continue Reading
-
Large-Scale Study Demonstrates Benefits of Early Nerivio REN Use for Migraine Treatmentne Treatment | NeurologyLive
A large-scale, real-world evidence study by Theranica found that early acute treatment with remote electrical neuromodulation (REN), or Nerivio, significantly reduced migraine outcomes. The study, titled The Effect of Treatment Onset Time on…
Continue Reading
-
Just a moment…
Just a moment… This request seems a bit unusual, so we need to confirm that you’re human. Please press and hold the button until it turns completely green. Thank you for your cooperation!
Continue Reading
-
Novo Nordisk’s CagriSema was associated with significant reduction in blood pressure and showed anti-inflammatory effects while reducing the proportion of patients at risk of developing heart disease over time in new analyses at ObesityWeek® USA – English USA – English
- A post hoc analysis of REDEFINE 1 demonstrated a 10.9 mmHg reduction in systolic blood pressure with investigational CagriSema (2.4 mg/2.4 mg), allowing 40% of people on blood…
Continue Reading
